Amylyx Pharma Stock (NASDAQ: AMLX) stock price, news, charts, stock research, profile.
Open | $1.65 |
Close | - |
Volume / Avg. | 843.70K / 1.87M |
Day Range | 1.62 - 1.68 |
52 Wk Range | 1.58 - 25.48 |
Market Cap | $114.93M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 11.67% |
Days to Cover | 6.81 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Amylyx Pharma (NASDAQ:AMLX) through any online brokerage.
Other companies in Amylyx Pharma’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST) and Telomir Pharmaceuticals (NASDAQ:TELO).
There is no analysis for Amylyx Pharma.
Amylyx Pharma has a consensus price target of $20.91.
The stock price for Amylyx Pharma (NASDAQ: AMLX) is $1.655 last updated Today at July 9, 2024 at 3:44 PM EDT.
There are no upcoming dividends for Amylyx Pharma.
Amylyx Pharma’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Amylyx Pharma.
Amylyx Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.